AKT1 and neoplasm: Resistin can activate signaling pathways such as JAK/STAT and PI3K/AKT, thereby influencing cell growth and angiogenesis within the tumor microenvironment, as well as suppressing the body’s anti-tumor immune response, indirectly facilitating the occurrence and progression of tumor bone metastasis.